Other Controls and Reagents
Avanti Polar Lipids 20:4 LYSO PI - 100UG
20:4 Lyso PI | 100ug 1-arachidonoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt)
Medchemexpress LLC DSPE-PEG2000-iRGD | 95.0% | 2000 (average) | 10 MG
DSPE-PEG2000-iRGD is a lipid-PEG conjugate formed by linking distearoylphosphatidylethanolamine to the tumor-penetrating iRGD peptide (CRGDKGPDC) via a PEG2000 spacer. Supplied as a powder, it is intended for surface functionalization of liposomes and nanoparticles to confer tumor-homing and tumor-penetrating properties for targeted drug delivery studies.
- Provides tumor-targeting via αv integrin binding.
- Promotes tumor penetration through neuropilin-1 interaction after proteolytic cleavage.
- Enables surface modification of liposomes and nanoparticles for targeted delivery.
- Contains a PEG2000 spacer for steric stabilization and extended circulation.
- Characterized by high purity and an average molecular weight for reproducible formulation.
Medchemexpress LLC DSPE-PEG2000-GE11 | 95.3% | 10 MG
DSPE-PEG2000-GE11 is a PEGylated lipid-peptide conjugate combining a DSPE lipid anchor, a PEG2000 spacer, and the EGFR-targeting GE11 peptide for targeted drug delivery and lipid nanoparticle formulation. It is designed to functionalize particle surfaces and direct therapeutic payloads to EGFR-overexpressing cells.
- Targets EGFR-overexpressing cancer cells.
- Provides a DSPE lipid anchor for membrane insertion.
- Includes a PEG2000 spacer to improve circulation and reduce opsonization.
- Contains the GE11 peptide for receptor-targeted delivery.
- Soluble in DMSO with sonication and warming to 60°C.
- Powder storage at -20°C; in solution store at -80°C for long-term.
Abcam SHU9119, Melanocortin 3 and 4 (MC3 and MC4) receptor antagonist, 1MG
MW 1074.25 g/mol, Purity >95%. Potent melanocortin 3 and 4 (MC₃ and MC₄) receptor antagonist (IC₅₀ values are 0.23 and 0.06 nM, respectively). Also shows MC₅ partial agonist activity (EC₅₀ = 0.12 nM). Dose-dependently increases food intake following central administration.
The product is subject to the following: Abcam Restricted Use Statement
eMolecules 1224606-06-7 | D-Lin-MC3-DMA | Broadpharm642.110 | C43H79NO2 | 99.000 | CCCCC\C=C/C\C=C/CCCCCCCCC(CCCCCCCC\C=C/C\C=C/CCCCC)OC(=O)CCCN(C)C | 100mg | 599128531
D-Lin-MC3-DMA | Broadpharm | 1224606-06-7642.110 | C43H79NO2 | 99.000 | CCCCC\C=C/C\C=C/CCCCCCCCC(CCCCCCCC\C=C/C\C=C/CCCCC)OC(=O)CCCN(C)C | 100mg | 599128531
Avanti Polar Lipids 17:0 Lyso PI-d5, 500µg
1-heptadecanoyl-2-hydroxy-sn-glycero(d5)-3-phosphoinositol (ammonium salt)
Medchemexpress LLC 1,2-distearoyl-sn-glycero-3-phosphorylcholine | 816-94-4 | MFCD00036905 | 100.0% | 790.15 | C44H88NO8P | 1 G
1,2-distearoyl-sn-glycero-3-phosphorylcholine (DSPC) is a saturated phospholipid used to formulate liposomes and as a structural lipid component in lipid nanoparticle systems. It is a white to off-white solid with high reported purity and defined storage recommendations.
- Used to synthesize liposomes and as a lipid component in lipid nanoparticle systems.
- White to off-white solid with high purity.
- Available in multiple pack sizes, including 1 g.
- Powder storage: -20°C for long-term stability.
- In solvent storage: -80°C for up to 6 months, -20°C for short-term storage.
Medchemexpress LLC Osm-smi-10b | 2502294-55-3 | 99.7% | 378.33 g·mol⁻¹ | C21H14O7 | 10 MG
OSM-SMI-10B is a small-molecule research inhibitor that significantly reduces oncostatin M (OSM)-induced STAT3 phosphorylation in cancer cells. It is intended for biochemical and cellular research into JAK/STAT signaling and STAT3-related pathways. The compound is supplied as a high-purity solid and has defined storage conditions for powder and solutions.
- Significantly reduces OSM-induced STAT3 phosphorylation in cellular assays.
- Directly targets phosphorylated STAT3 (p-STAT3) in the JAK/STAT pathway.
- High purity (99.7%) suitable for research applications.
- Molecular formula C21H14O7; molecular weight 378.33 g·mol⁻¹.
- Powder storage: -20°C for 3 years, 4°C for 2 years.
- In solvent storage: -80°C for 6 months, -20°C for 1 month.
Apexbio Technology LLC DMG-PEG2000-Biotin(Synonyms: DMG-PEG-Biotin, Biotinylated DMG-PEG2000, DMG-PEG2000-Biotin Conjugate), 50mg.
DMG-PEG2000-Biotin is a synthetic amphiphilic molecule composed of dimyristoyl glycerol (DMG) polyethylene glycol (PEG2000) and biotin functionalities It is commonly employed in biomedical research for surface modification of lipid-based delivery platforms such as lipid nanoparticles (LNPs) and liposomes The PEG moiety enhances colloidal stability prolongs circulation time and reduces rapid clearance in vivo The biotin termination facilitates conjugation to streptavidin-tagged biomolecules exploiting the highly specific biotin-streptavidin interaction Thus DMG-PEG2000-Biotin is valuable for drug-delivery optimization targeted therapeutic approaches and in vitro diagnostic assay development
Avanti Polar Lipids 16:0 PC (DPPC), 63-89-8, 11g
Molecular Formula C40H80NO8P, Purity >99%, Formula Weight 734.039, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
Creative Biomart Recombinant CMV Pp52 Antigen, GST-tagged
The E. coli derived 51 kDa recombinant protein contains the CMV Pp52 (UL44) immunodominant regions, 202-434 amino acids. Recombinant CMV-Pp52 is fused to a 26 kDa GST tag.
Avanti Polar Lipids 1-PALMITOYL-2-(5'-OXO-VALE 1MG
1-PALMITOYL-2-(5'-OXO-VALEROYL)-SN-GLYCERO-3-PHOSPHOCHOLINE | 121324-31-0 | MFCD05863929 | 1 mg